This rapid, automated DNA test detects active Tuberculosis (M.Tb) and checks for resistance to the two most critical first-line TB medications: Rifampicin and Isoniazid.

Using advanced CBNAAT (GeneXpert) technology, the test analyzes samples (like sputum, fluid, or tissue) to identify bacterial DNA within hours. Simultaneously, it maps genetic mutations responsible for drug resistance.

By confirming whether the infection is standard TB or drug-resistant TB (such as MDR-TB), this test prevents critical treatment delays. It allows doctors to bypass weeks of traditional lab cultures and immediately prescribe the most effective, lifesaving antibiotic regimen.